119 related articles for article (PubMed ID: 15892167)
1. Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma.
Seliger B; Lichtenfels R; Atkins D; Bukur J; Halder T; Kersten M; Harder A; Ackermann A; Malenica B; Brenner W; Zobawa M; Lottspeich F
Proteomics; 2005 Jul; 5(10):2631-40. PubMed ID: 15892167
[TBL] [Abstract][Full Text] [Related]
2. Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma.
Teratani T; Domoto T; Kuriki K; Kageyama T; Takayama T; Ishikawa A; Ozono S; Nozawa R
Urology; 2007 Feb; 69(2):236-40. PubMed ID: 17320655
[TBL] [Abstract][Full Text] [Related]
3. Molecular prognostic factor in renal cell carcinoma.
Shimazui T; Oosterwijk E; Debruyne FM; Schalken JA
Semin Urol Oncol; 1996 Nov; 14(4):250-5. PubMed ID: 8946626
[TBL] [Abstract][Full Text] [Related]
4. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
Sejima T; Miyagawa I
Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
[TBL] [Abstract][Full Text] [Related]
5. Exploring the pathogenesis of renal cell carcinoma: pathway and bioinformatics analysis of dysregulated genes and proteins.
Romaschin AD; Youssef Y; Chow TF; Siu KW; DeSouza LV; Honey RJ; Stewart R; Pace KT; Yousef GM
Biol Chem; 2009 Feb; 390(2):125-35. PubMed ID: 19090715
[TBL] [Abstract][Full Text] [Related]
6. Gene signatures of progression and metastasis in renal cell cancer.
Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma.
Craven RA; Stanley AJ; Hanrahan S; Dods J; Unwin R; Totty N; Harnden P; Eardley I; Selby PJ; Banks RE
Proteomics; 2006 May; 6(9):2853-64. PubMed ID: 16596713
[TBL] [Abstract][Full Text] [Related]
8. Detection of circulating tumor cells from renal carcinoma patients: experiences of a two-center study.
Blümke K; Bilkenroth U; Schmidt U; Melchior A; Füssel S; Bartel F; Heynemann H; Fornara P; Taubert H; Wirth MP; Meye A
Oncol Rep; 2005 Oct; 14(4):895-9. PubMed ID: 16142348
[TBL] [Abstract][Full Text] [Related]
9. The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma.
Hwa JS; Kim HJ; Goo BM; Park HJ; Kim CW; Chung KH; Park HC; Chang SH; Kim YW; Kim DR; Cho GJ; Choi WS; Kang KR
Proteomics; 2006 Feb; 6(3):1077-84. PubMed ID: 16372272
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability.
Eichelberg C; Junker K; Ljungberg B; Moch H
Eur Urol; 2009 Apr; 55(4):851-63. PubMed ID: 19155123
[TBL] [Abstract][Full Text] [Related]
12. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.
Saini S; Liu J; Yamamura S; Majid S; Kawakami K; Hirata H; Dahiya R
Cancer Res; 2009 Sep; 69(17):6815-22. PubMed ID: 19723665
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
14. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.
Elsamman EM; Fukumori T; Tanimoto S; Nakanishi R; Takahashi M; Toida K; Kanayama HO
BJU Int; 2006 Sep; 98(3):668-73. PubMed ID: 16925770
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of renal cell carcinoma.
Tan MH; Rogers CG; Cooper JT; Ditlev JA; Maatman TJ; Yang X; Furge KA; Teh BT
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6315S-21S. PubMed ID: 15448024
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
[TBL] [Abstract][Full Text] [Related]
17. Panel of candidate biomarkers for renal cell carcinoma.
Kim DS; Choi YP; Kang S; Gao MQ; Kim B; Park HR; Choi YD; Lim JB; Na HJ; Kim HK; Nam YP; Moon MH; Yun HR; Lee DH; Park WM; Cho NH
J Proteome Res; 2010 Jul; 9(7):3710-9. PubMed ID: 20455597
[TBL] [Abstract][Full Text] [Related]
18. Down-regulated expression of RhoA in human conventional renal cell carcinoma.
Pu YS; Wang CW; Liu GY; Kuo YZ; Huang CY; Kang WY; Shun CT; Lin CC; Wu WJ; Hour TC
Anticancer Res; 2008; 28(4B):2039-43. PubMed ID: 18751372
[TBL] [Abstract][Full Text] [Related]
19. Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues.
Perego RA; Bianchi C; Corizzato M; Eroini B; Torsello B; Valsecchi C; Di Fonzo A; Cordani N; Favini P; Ferrero S; Pitto M; Sarto C; Magni F; Rocco F; Mocarelli P
J Proteome Res; 2005; 4(5):1503-10. PubMed ID: 16212400
[TBL] [Abstract][Full Text] [Related]
20. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
